by jlohrconsulting | Aug 22, 2025 | Uncategorized
Neurol Clin Pract. 2025 Oct;15(5):e200521. doi: 10.1212/CPJ.0000000000200521. Epub 2025 Aug 19. ABSTRACT OBJECTIVES: Lafora disease (LD) is a fatal progressive myoclonic epilepsy, characterized by disabling myoclonus, intractable seizures, and progressive cognitive...
by jlohrconsulting | Aug 22, 2025 | Uncategorized
Front Vet Sci. 2025 Aug 6;12:1598311. doi: 10.3389/fvets.2025.1598311. eCollection 2025. ABSTRACT While the efficacy of repetitive transcranial magnetic stimulation (rTMS) has been explored in humans and, to a lesser extent, in dogs with epilepsy, further clinical...
by jlohrconsulting | Aug 22, 2025 | Uncategorized
Front Pharmacol. 2025 Aug 6;16:1578406. doi: 10.3389/fphar.2025.1578406. eCollection 2025. ABSTRACT BACKGROUND: Temozolomidee (TMZ) is an alkylating antitumor drug used in the treatment of glioblastoma and anaplastic astrocytoma. It is often combined with radiotherapy...
by jlohrconsulting | Aug 22, 2025 | Uncategorized
Gut Pathog. 2025 Aug 21;17(1):65. doi: 10.1186/s13099-025-00739-8. ABSTRACT BACKGROUND: Lactobacillus reuteri DSM 17,938 exhibits antidepressant and anxiolytic potential. The purpose of this study is to validate the effects of L. reuteri DSM 17,938 and preliminarily...
by jlohrconsulting | Aug 22, 2025 | Uncategorized
BMC Public Health. 2025 Aug 21;25(1):2868. doi: 10.1186/s12889-025-24220-y. ABSTRACT OBJECTIVE: To create and verify a machine learning model that integrates social determinants of health (SDoH) for assessing post-stroke depression (PSD) and examining the association...
Recent Comments